David Miller

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

Alasdair Coles, Mark Wing, Paul Molyneux et al. · Annals of Neurology · 1999 · 498 citations

Neurological Disorder, Immunology, Immunotherapy +20

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.

Gilles Edan, David Miller, M. Clanet et al. · Journal of Neurology Neurosurgery & Psychiatry · 1997 · 422 citations · Full text

Eight-year follow-up study of brain atrophy in patients with MS

Elizabeth Fisher, Richard A. Rudick, Jack H. Simon et al. · Neurology · 2002 · 375 citations

Spinal-cord MRI in multiple sclerosis

Geert J. Lycklama, Alan J. Thompson, Massimo Filippi et al. · The Lancet Neurology · 2003 · 228 citations

Spinal Cord Injury, Neurological Disorder, Neuroimaging +5

Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis

Neil Scolding, David Barnes, Sarah Cader et al. · Practical Neurology · 2015 · 219 citations · Full text